Skip to main content

Nanosuspensions Downstream Processing - Strategies and Key Facts for Oral Dosage Forms

Thank you

This live web event has ended. Thank you for attending.


  • Paolo Gatti

    Paolo Gatti is Senior Vice President Pharmaceutical Development Scientific Direction at the Evotec site in Verona, Italy.
    Prior to joining Evotec in 2017, Paolo was head of product development at BSP Pharmaceuticals (Latina, Italy), a global manufacturing and development services provider in the field of conventional and biotech oncological drugs. He started his career in 1999 as a formulation scientist at Pharmacia & Upjohn (Nerviano) and he held positions of increasing responsibility in pharmaceutical development at Pharmacia, Pfizer, Eurand and Adare Pharmaceuticals.
    Amongst his career achievements is the contribution as pharmaceutical development team leader to the successful registration in USA, Europe and Japan of Pfizer’s new anticancer drug sunitinib maleate.
    Paolo’s background and research interests include development of formulations to speed-up new chemical entity clinical studies; bioavailability improvement of poorly soluble drugs; patient-centric dosage from development, oral solid and freeze dried dosage forms process development and scale-up.
    He is faculty member of Master Courses at the Universities of Pavia and Siena and is invited lecturer at other universities and professional advancement courses. He is author of peer reviewed papers and patents and is the co-author of a book on Pharmaceutical Industry Equipment and Processes.

  • Pascale Clement

    Pascale is a passionate, results-driven leader with over 20 years’ experience working in international drug development - from early stage to commercial. Known for her rigorous scientific approach, organizational skills and team leadership; Pascale’s core expertise is in bioavailability enhancement and development of various dosage forms. She has taken progressive leadership roles working at Skyepharma and Pharmascience (Canada), at HWI Analytik (Germany) where she led a Project Management and Pharmaceutical Development team and at Catalent as Director of Science & Technology for Europe and as Director Project Management for the Catalent German Softgel site. She has recently been appointed as the Chief Technology Officer at leon-nanodrugs. Pascale graduated with a Ph.D. in Pharmaceutical Sciences from Paris XI University. When not working Pascale can be found running or swimming.

October 20, 2020
Tue 12:30 PM EDT

Duration 1H 30M

This live web event has ended.